JAK2 and ovarian carcinoma: miR-503-5p suppression plays a critical role in CD97 expression (a member of the epidermal growth factor (EGF)—seven-transmembrane family, expressed in many cancers) and the related JAK2/STAT3 pathway for enhancing the metastasis of paclitaxel-resistant ovarian cancer cells [49].